Intech Biopharm (ROCO:6461) Long-Term Debt : NT$878.59 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Intech Biopharm Long-Term Debt?

Intech Biopharm's Long-Term Debt for the quarter that ended in Mar. 2024 was NT$878.59 Mil.

Intech Biopharm's quarterly Long-Term Debt declined from Sep. 2023 (NT$1,062.20 Mil) to Dec. 2023 (NT$970.41 Mil) and declined from Dec. 2023 (NT$970.41 Mil) to Mar. 2024 (NT$878.59 Mil).

Intech Biopharm's annual Long-Term Debt increased from Dec. 2021 (NT$940.77 Mil) to Dec. 2022 (NT$1,143.43 Mil) but then declined from Dec. 2022 (NT$1,143.43 Mil) to Dec. 2023 (NT$970.41 Mil).

Intech Biopharm Long-Term Debt Historical Data

The historical data trend for Intech Biopharm's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intech Biopharm Long-Term Debt Chart

Intech Biopharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

829.63

1,138.20

940.77

1,143.43

970.41

Intech Biopharm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															1,135.10	1,112.85	1,062.20	970.41	878.59

Intech Biopharm (ROCO:6461) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Intech Biopharm Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Intech Biopharm's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Intech Biopharm (ROCO:6461) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intech Biopharm Ltd (ROCO:6461) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ruiguang Road, Neihu District, 3rd Floor, No. 36, Lane 358, Neihu, Taipei, TWN

Website

http://www.intechbiopharm.com

Intech Biopharm Ltd is a biotechnology company. The company develops inhalation products including single or combination generic products and some new combinations or new formulation projects are under development. It develops drugs for the treatment of lung diseases such as asthma.

Intech Biopharm (ROCO:6461) Headlines

No Headlines